Fundraising FoxNextera
1 known investors
Find your way into Nextera
Nextera develops TCR-Like antibody drug candidates that target disease-specific pHLA antigens for cancer, autoimmune, and inflammatory diseases. It uses protein engineering and phage display technology to build targeted immunotherapies aimed at intracellular disease antigens.
Investors · 1
Frequently asked questions
- What does Nextera do?
- Nextera develops TCR-Like antibody drug candidates that target disease-specific pHLA antigens for cancer, autoimmune, and inflammatory diseases. It uses protein engineering and phage display technology to build targeted immunotherapies aimed at intracellular disease antigens.
- Who are Nextera's investors?
- Nextera's investors include Birk Venture.